Early Phase 1 Lupus Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 75 years old (any gender)
- You have been officially diagnosed with systemic lupus erythematosus (SLE — a type of autoimmune disease) based on recognised medical guidelines
- Your SLE has not responded well enough to at least 2 standard treatments tried for at least 3 months each
- Your SLE is currently considered active enough, based on specific medical scoring tools used by your doctor (confirm with trial site)
- Your bone marrow, liver, kidneys, blood clotting, and heart are functioning at a minimum acceptable level, as measured by blood tests (confirm with trial site)
- If you are a woman who could become pregnant, you must have a negative pregnancy test within 7 days before joining and agree to use reliable contraception (or abstain) during the study and for at least 6 months after treatment ends, and you must not be breastfeeding
- If you are a man whose partner could become pregnant, you must also agree to use reliable contraception (or abstain) during the study and for at least 6 months after treatment ends
- You are willing to take part voluntarily, sign a consent form, and follow the study schedule
Who may not be able to join:
- You have a history of severe drug allergies or a general tendency toward allergic conditions
- You currently have, or are suspected to have, an active infection (such as a bacterial, viral, or fungal infection) that is not under control
- Your heart is not strong enough to handle the study treatment (confirm with trial site)
- You were born with a condition that means your immune system cannot produce enough antibodies (immunoglobulin deficiency)
- You have had a cancer diagnosis within the past 5 years
- Your kidneys have reached end-stage failure
- You have active hepatitis B, hepatitis C, HIV, or syphilis, based on specific blood test results (confirm with trial site)
- You have a history of mental illness or severe problems with thinking or memory
- You have recently taken certain immune-suppressing medications or biological treatments within a specified time before joining (confirm exact timeframes with trial site)
- You are currently pregnant or planning to become pregnant
- Your doctor determines there is any other reason you should not take part in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Tao Wang, M.D., The General Hospital of Western Theater Command
Phone: +8613550080505
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
the incidence rate of Dose limited toxicity (DLTs); the rate of adverse events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.